Human herpesvirus-6 entry into host cells

Future Microbiology

Volumn 5, Issue 7, 2010, Pages 1015-1023

  Tang, Huamin ^a   Mori, Yasuko ^a,b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

entry; FFWO; glycoprotein complex; gQ1 gQ2 gH gL; HHV 6; lipid rafts

Indexed keywords

GLYCOPROTEIN; VIRUS RECEPTOR; CD46 PROTEIN, HUMAN; MEMBRANE COFACTOR PROTEIN; VIRUS ENVELOPE PROTEIN;

ENDOCYTOSIS; HERPES VIRUS INFECTION; HOST CELL; HUMAN; HUMAN HERPESVIRUS 6; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS ENTRY; BIOLOGICAL MODEL; CELL MEMBRANE; METABOLISM; PHYSIOLOGY;

HERPESVIRIDAE; HUMAN HERPESVIRUS 6;

ANTIGENS, CD46; HERPESVIRUS 6, HUMAN; HUMANS; MEMBRANE MICRODOMAINS; MODELS, BIOLOGICAL; RECEPTORS, VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

EID: 77954733578     PISSN: 17460913     EISSN: None     Source Type: Journal    
DOI: 10.2217/fmb.10.61     Document Type: Review

References (99)

1. Dockrell DH: Human herpesvirus 6: molecular biology and clinical features. J. Med. Microbiol. 52(Pt 1), 5-18(2003).
2. Roizman B: The structure and isomerization of herpes simplex virus genomes. Cell 16(3), 481-494 (1979).
3. Salahuddin SZ, Ablashi DV, Markham PD et al.: Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234(4776), 596-601 (1986).
4. Ablashi DV, Balachandran N, Josephs SF et al.: Genomic polymorphism, growth properties, and immunologic variations in human herpesvirus-6 isolates. Virology 184(2), 545-552 (1991).
5. Aubin JT, Collandre H, Candotti D et al.: Several groups among human herpesvirus 6 strains can be distinguished by Southern blotting and polymerase chain reaction. J. Clin. Microbiol. 29(2), 367-372 (1991).
6. Campadelli-Fiume G, Guerrini S, Liu X, Foa-Tomasi L: Monoclonal antibodies to glycoprotein B differentiate human herpesvirus 6 into two clusters, variants Aand B. J. Gen. Virol. 74(Pt 10), 2257-2262 (1993).
7. Wyatt LS, Balachandran N, Frenkel N: Variations in the replication and antigenic properties of human herpesvirus 6 strains. J. Infect. Dis. 162(4), 852-857(1990).
8. Asano Y, Yoshikawa T, Suga S et al.: Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics 93(1), 104-108(1994).
9. Hall CB, Long CE, Schnabel KC et al.: Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N. Engl. J. Med. 331(7), 432-438(1994).
10. Portolani M, Cermelli C, Moroni Aet al.: Human herpesvirus-6 infections in infants admitted to hospital. J. Med. Virol. 39(2), 146-151 (1993).
11. Okuno T, Takahashi K, Balachandra Ket al.: Seroepidemiology of human herpesvirus 6 infection in normal children and adults. J. Clin. Microbiol. 27(4), 651-653 (1989).
12. Mukai T, Yamamoto T, Kondo T et al.: Molecular epidemiological studies of human herpesvirus 6 in families. J. Med. Virol. 42(3), 224-227(1994).
13. Tanaka-Taya K, Kondo T, Mukai T et al.: Seroepidemiological study of human herpesvirus-6 and -7in children of different ages and detection of these two viruses in throat swabs by polymerase chain reaction. J. Med. Virol. 48(1), 88-94 (1996).
14. van Loon NM, Gummuluru S, Sherwood DJ, Marentes R, Hall CB, Dewhurst S: Direct sequence analysis of human herpesvirus 6 (HHV-6) sequences from infants and comparison of HHV-6 sequences from mother/infant pairs. Clin. Infect. Dis. 21(4), 1017-1019 (1995).
15. Dewhurst S, McIntyre K, Schnabel K, Hall CB: Human herpesvirus 6 (HHV-6) variant B accounts for the majority of symptomatic primary HHV-6 infections in a population of U.S. infants. J. Clin. Microbiol. 31(2), 416-418(1993).
16. Schirmer EC, Wyatt LS, Yamanishi K, Rodriguez WJ, Frenkel N: Differentiation between two distinct classes of viruses now classified as human herpesvirus 6. Proc. Natl Acad. Sci. USA 88(13), 5922-5926 (1991).
17. Braun DK, Dominguez G, Pellett PE: Human herpesvirus 6. Clin. Microbiol. Rev. 10(3), 521-567(1997).
18. Kondo K, Kondo T, Okuno T, Takahashi M, Yamanishi K: Latent human herpesvirus 6 infection of human monocytes/macrophages. J. Gen. Virol. 72(Pt 6), 1401-1408(1991).
19. Luppi M, Barozzi P, Morris C et al.: Human herpesvirus 6 latently infects early bone marrow progenitors in vivo. J. Virol. 73(1), 754-759 (1999).
20. Drobyski WR, Eberle M, Majewski D, Baxter-Lowe LA: Prevalence of human herpesvirus 6 variant Aand B infections in bone marrow transplant recipients as determined by polymerase chain reaction and sequence-specific oligonucleotide probe hybridization. J. Clin. Microbiol. 31(6), 1515-1520 (1993).
21. Knox KK, Carrigan DR: Disseminated active HHV-6 infections in patients with AIDS. Lancet 343(8897), 577-578(1994).
22. Knox KK, Carrigan DR: Active human herpesvirus (HHV-6) infection of the central nervous system in patients with AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 9(1), 69-73 (1995).
23. Knox KK, Harrington DP, Carrigan DR: Fulminant human herpesvirus six encephalitis in a human immunodeficiency virus-infected infant. J. Med. Virol. 45(3), 288-292 (1995).
24. Wang FZ, Linde A, Dahl H, Ljungman P: Human herpesvirus 6 infection inhibits specific lymphocyte proliferation responses and is related to lymphocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant. 24(11), 1201-1206 (1999).
25. Caserta MT, Mock DJ, Dewhurst S: Human herpesvirus 6. Clin. Infect. Dis. 33(6), 829-833 (2001).
26. Kamm RD: Cellular fluid mechanics. Annu. Rev. Fluid Mech. 34, 211-232 (2002).
27. Flint SJ, Enquist LW, Racaniello VR, Skalka AM: Principles of Virology. ASM Press, DC, USA(2004).
28. Poranen MM, Daugelavicius R, Bamford DH: Common principles in viral entry. Annu. Rev. Microbiol. 56, 521-538(2002).
29. Spear PG, Longnecker R: Herpesvirus entry: an update. J. Virol. 77(19), 10179-10185 (2003).
30. Montgomery RI, Warner MS, Lum BJ, Spear PG: Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/ NGF receptor family. Cell 87(3), 427-436 (1996).
31. Mori Y, Yang X, Akkapaiboon P, Okuno T, Yamanishi K: Human herpesvirus 6 variant Aglycoprotein H-glycoprotein L-glycoprotein Q complex associates with human CD46. J. Virol. 77(8), 4992-4999 (2003).
32. Santoro F, Kennedy PE, Locatelli G, Malnati MS, Berger EA, Lusso P: CD46 is a cellular receptor for human herpesvirus 6. Cell 99(7), 817-827(1999).
33. Shukla D, Liu J, Blaiklock P et al.: Anovel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99(1), 13-22 (1999).
34. Reske A, Pollara G, Krummenacher C, Chain BM, Katz DR: Understanding HSV-1 entry glycoproteins. Rev. Med. Virol. 17(3), 205-215 (2007).
35. Hutt-Fletcher LM: Epstein-Barr virus entry. J. Virol. 81(15), 7825-7832 (2007).
36. Nowak SA, Chou T: Mechanisms of receptor/coreceptor-mediated entry of enveloped viruses. Biophys. J. 96(7), 2624-2636 (2009).
37. Takahashi K, Sonoda S, Higashi Ket al.: Predominant CD4 T-lymphocyte tropism of human herpesvirus 6-related virus. J. Virol. 63(7), 3161-3163 (1989).
38. Lusso P, Malnati MS, Garzino-Demo A, Crowley RW, Long EO, Gallo RC: Infection of natural killer cells by human herpesvirus 6. Nature 362(6419), 458-462 (1993). (Pubitemid 23107371)
39. Cermelli C, Concari M, Carubbi F et al.: Growth of human herpesvirus 6 in HEPG2 cells. Virus Res. 45(2), 75-85 (1996).
40. Chen M, Popescu N, Woodworth C et al.: Human herpesvirus 6 infects cervical epithelial cells and transactivates human papillomavirus gene expression. J. Virol. 68(2), 1173-1178(1994).
41. Caruso A, Rotola A, Comar M et al.: HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J. Med. Virol. 67(4), 528-533 (2002).
42. He J, McCarthy M, Zhou Y, Chandran B, Wood C: Infection of primary human fetal astrocytes by human herpesvirus 6. J. Virol. 70(2), 1296-1300 (1996).
43. Kakimoto M, Hasegawa A, Fujita S, Yasukawa M: Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection. J. Virol. 76(20), 10338-10345 (2002).
44. Ablashi DV, Salahuddin SZ, Josephs SF, Balachandran N, Krueger GR, Gallo RC: Human herpesvirus-6 (HHV-6) (short review). In Vivo 5(3), 193-199 (1991).
45. Naesens L, Bonnafous P, Agut H, De Clercq E: Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts. J. Clin. Virol. 37(Suppl. 1), S69-S75 (2006).
46. Donati D, Akhyani N, Fogdell-Hahn Aet al.: Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61(10), 1405-1411 (2003).
47. Luppi M, Barozzi P, Maiorana Aet al.: Human herpesvirus-6: a survey of presence and distribution of genomic sequences in normal brain and neuroglial tumors. J. Med. Virol. 47(1), 105-111 (1995).
48. Chan PK, Ng HK, Hui M, Cheng AF: Prevalence and distribution of human herpesvirus 6 variants Aand B in adult human brain. J. Med. Virol. 64(1), 42-46 (2001).
49. Ozaki Y, Tajiri H, Tanaka-Taya Ket al.: Frequent detection of the human herpesvirus 6-specific genomes in the livers of children with various liver diseases. J. Clin. Microbiol. 39(6), 2173-2177(2001).
50. Harma M, Hockerstedt K, Lautenschlager I: Human herpesvirus-6 and acute liver failure. Transplantation 76(3), 536-539 (2003).
51. Ishikawa K, Hasegawa K, Naritomi T et al.: Prevalence of herpesviridae and hepatitis virus sequences in the livers of patients with fulminant hepatitis of unknown etiology in Japan. J. Gastroenterol. 37(7), 523-530 (2002).
52. Fox JD, Briggs M, Ward PA, Tedder RS: Human herpesvirus 6 in salivary glands. Lancet 336(8715), 590-593 (1990).
53. Roush KS, Domiati-Saad RK, Margraf LR et al.: Prevalence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue. Am. J. Clin. Pathol. 116(5), 648-654 (2001).
54. Higashi K, Asada H, Kurata T et al.: Presence of antibody to human herpesvirus 6 in monkeys. J. Gen. Virol. 70(Pt 12), 3171-3176 (1989).
55. De Bolle L, Naesens L, De Clercq E: Update on human herpesvirus 6 biology, clinical features, and therapy. Clin. Microbiol. Rev. 18(1), 217-245 (2005).
56. Yalcin S, Mukai T, Kondo Ket al.: Experimental infection of cynomolgus and African green monkeys with human herpesvirus 6. J. Gen. Virol. 73(Pt ), 1673-1677(1992).
57. Cirone M, Zompetta C, Angeloni Aet al.: Infection by human herpesvirus 6 (HHV-6) of human lymphoid T cells occurs through an endocytic pathway. AIDS Res. Hum. Retroviruses 8(12), 2031-2037(1992).
58. Riley-Vargas RC, Gill DB, Kemper C, Liszewski MK, Atkinson JP: CD46: expanding beyond complement regulation. Trends Immunol. 25(9), 496-503 (2004).
59. Liszewski MK, Kemper C, Price JD, Atkinson JP: Emerging roles and new functions of CD46. Springer Semin. Immunopathol. 27(3), 345-358(2005).
60. Greenstone HL, Santoro F, Lusso P, Berger EA: Human herpesvirus 6 and measles virus employ distinct CD46 domains for receptor function. J. Biol. Chem. 277(42), 39112-39118(2002).
61. Seya T, Hara T, Matsumoto M, Sugita Y, Akedo H: Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46). J. Exp. Med. 172(6), 1673-1680 (1990).
62. Manchester M, Gairin JE, Patterson JB et al.: Measles virus recognizes its receptor, CD46, via two distinct binding domains within SCR1-2. Virology 233(1), 174-184 (1997).
63. Mori Y, Seya T, Huang HL, Akkapaiboon P, Dhepakson P, Yamanishi K: Human herpesvirus 6 variant but not variant B induces fusion from without in a variety of human cells through a human herpesvirus 6 entry receptor, CD46. J. Virol. 76(13), 6750-6761 (2002).
64. Akhtar J, Shukla D: Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J. 276(24), 7228-7236 (2009).
65. Pertel PE, Fridberg A, Parish ML, Spear PG: Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate. Virology 279(1), 313-324 (2001).
66. Muggeridge MI: Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH and gL in transfected cells. J. Gen. Virol. 81(Pt 8), 2017-2027(2000).
67. Turner A, Bruun B, Minson T, Browne H: Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system. J. Virol. 72(1), 873-875 (1998).
68. Dominguez G, Dambaugh TR, Stamey FR, Dewhurst S, Inoue N, Pellett PE: Human herpesvirus 6B genome sequence: coding content and comparison with human herpesvirus 6A. J. Virol. 73(10), 8040-8052 (1999).
69. Isegawa Y, Mukai T, Nakano Ket al.: Comparison of the complete DNAsequences of human herpesvirus 6 variants Aand B. J. Virol. 73(10), 8053-8063 (1999).
70. Anderson RA, Liu DX, Gompels UA: Definition of a human herpesvirus-6 bherpesvirus-specific domain in glycoprotein gH that governs interaction with glycoprotein gL: substitution of human cytomegalovirus glycoproteins permits group-specific complex formation. Virology 217(2), 517-526 (1996).
71. Santoro F, Greenstone HL, Insinga Aet al.: Interaction of glycoprotein H of human herpesvirus 6 with the cellular receptor CD46. J. Biol. Chem. 278(28), 25964-25969 (2003).
72. Takeda K, Okuno T, Isegawa Y, Yamanishi K: Identification of a variant A-specific neutralizing epitope on glycoprotein B (gB) of human herpesvirus-6 (HHV-6). Virology 222(1), 176-183 (1996).
73. O'Donnell CD, Shukla D: The importance of heparan sulfate in herpesvirus infection. Virol. Sin. 23(6), 383-393 (2008).
74. Wille PT, Knoche AJ, Nelson JA, Jarvis MA, Johnson DC: An HCMV gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts, epithelial, and endothelial cells. J. Virol. 84(5), 2585-2596 (2009).
75. Compton T, Nepomuceno RR, Nowlin DM: Human cytomegalovirus penetrates host cells by pH-independent fusion at the cell surface. Virology 191(1), 387-395 (1992).
76. Hobom U, Brune W, Messerle M, Hahn G, Koszinowski UH: Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J. Virol. 74(17), 7720-7729 (2000).
77. Jiang XJ, Adler B, Sampaio KL et al.: UL74 of human cytomegalovirus contributes to virus release by promoting secondary envelopment of virions. J. Virol. 82(6), 2802-2812 (2008).
78. Scrivano L, Esterlechner J, Muhlbach H et al.: The m74 gene product of murine cytomegalovirus (MCMV) is a functional homolog of human CMV gO and determines the entry pathway of MCMV. J. Virol. 84(9), 4469-4480 (2010).
79. Ryckman BJ, Chase MC, Johnson DC: Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J. Virol. 84(5), 2597-2609 (2010).
80. Wille PT, Knoche AJ, Nelson JA, Jarvis MA, Johnson DC: Ahuman cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J. Virol. 84(5), 2585-2596 (2010).
81. Mori Y, Akkapaiboon P, Yonemoto S et al.: Discovery of a second form of tripartite complex containing gH-gL of human herpesvirus 6 and observations on CD46. J. Virol. 78(9), 4609-4616 (2004).
82. Pfeiffer B, Thomson B, Chandran B: Identification and characterization of a cDNAderived from multiple splicing that encodes envelope glycoprotein gp105 of human herpesvirus 6. J. Virol. 69(6), 3490-3500 (1995).
83. Akkapaiboon P, Mori Y, Sadaoka T, Yonemoto S, Yamanishi K: Intracellular processing of human herpesvirus 6 glycoproteins Q1 and Q2 into tetrameric complexes expressed on the viral envelope. J. Virol. 78(15), 7969-7983 (2004).
84. Mori Y, Akkapaiboon P, Yang X, Yamanishi K: The human herpesvirus 6 U100 gene product is the third component of the gH-gL glycoprotein complex on the viral envelope. J. Virol. 77(4), 2452-2458(2003).
85. Ryckman BJ, Jarvis MA, Drummond DD, Nelson JA, Johnson DC: Human cytomegalovirus entry into epithelial and endothelial cells depends on genes UL128to UL150 and occurs by endocytosis and low-pH fusion. J. Virol. 80(2), 710-722 (2006).
86. Ryckman BJ, Rainish BL, Chase MC et al.: Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J. Virol. 82(1), 60-70 (2008).
87. Pedersen SM, Hollsberg P: Complexities in human herpesvirus-6Aand -6B binding to host cells. Virology 356(1-2), 1-3 (2006).
88. Simons K, Ikonen E: Functional rafts in cell membranes. Nature 387(6633), 569-572 (1997).
89. Simons K, Toomre D: Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1(1), 31-39 (2000).
90. Manes S, del Real G, Lacalle RAet al.: Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep. 1(2), 190-196 (2000).
91. Rawat SS, Viard M, Gallo SA, Rein A, Blumenthal R, Puri A: Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol. Membr. Biol. 20(3), 243-254 (2003).
92. Huang H, Li Y, Sadaoka T et al.: Human herpesvirus 6 envelope cholesterol is required for virus entry. J. Gen. Virol. 87(Pt 2), 277-285 (2006).
93. Tang H, Kawabata A, Takemoto M, Yamanishi K, Mori Y: Human herpesvirus-6 infection induces the reorganization of membrane microdomains in target cells, which are required for virus entry. Virology 378(2), 265-271 (2008).
94. Kawabata A, Tang H, Huang H, Yamanishi K, Mori Y: Human herpesvirus 6 envelope components enriched in lipid rafts: evidence for virion-associated lipid rafts. Virol. J. 6, 127(2009).
95. Walev I, Wollert KC, Weise K, Falke D: Characterization of fusion from without induced by herpes simplex virus. Arch. Virol. 117(1-2), 29-44 (1991).
96. Bratt MA, Gallaher WR: Preliminary analysis of the requirements for fusion from within and fusion from without by Newcastle disease virus. Proc. Natl Acad. Sci. USA 64(2), 536-543 (1969).
97. Saharkhiz-Langroodi A, Holland TC: Identification of the fusion-from-without determinants of herpes simplex virus type 1 glycoprotein B. Virology 227(1), 153-159 (1997).
98. Pedersen SM, Oster B, Bundgaard B, Hollsberg P: Induction of cell-cell fusion from without by human herpesvirus 6B. J. Virol. 80(19), 9916-9920 (2006).
99. Subramanian RP, Geraghty RJ: Herpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and B. Proc. Natl Acad. Sci. USA 104(8), 2903-2908(2007).